The global selmonitoring blood glucose devices market is expected to grow at a CAGR of 5.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of diabetes and rising awareness about diabetes among people. The global selmonitoring blood glucose devices market is segmented on the basis of type, application, and region. On the basis of type, it can be segmented into strips and meters; on the basis of application, it can be segmented into public hospitals, private hospitals, clinics and pharmacy shops; on the basis of region it can be segmented into North America (US), Latin America (Mexico), Europe (UK), Asia Pacific (China) and Middle East & Africa (Saudi Arabia).
Some Of The Growth Factors Of This Market:
- The increasing awareness about diabetes and its complications among people is also expected to fuel the demand for self-monitoring blood glucose devices in the near future.
- In addition, technological advancements in these devices are also expected to drive their adoption over time as they offer more accurate results than traditional methods such as finger prick tests or urine tests for sugar levels.
Industry Growth Insights published a new data on “Self-monitoring Blood Glucose Devices Market”. The research report is titled “Self-monitoring Blood Glucose Devices Market research by Types (Strips, Glucose Meter, Lancet, Other), By Applications (Public Hospital, Private Hospital, Clinics, Pharmacy Shops), By Players/Companies Roche Roche Diagnostics, Lifescan, Abbott Laboratories, Terumo, Ascensia (Bayer)”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Self-monitoring Blood Glucose Devices Market Research Report
By Type
Strips, Glucose Meter, Lancet, Other
By Application
Public Hospital, Private Hospital, Clinics, Pharmacy Shops
By Companies
Roche Roche Diagnostics, Lifescan, Abbott Laboratories, Terumo, Ascensia (Bayer)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Self-monitoring Blood Glucose Devices Market Report Segments:
The global Self-monitoring Blood Glucose Devices market is segmented on the basis of:
Types
Strips, Glucose Meter, Lancet, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Public Hospital, Private Hospital, Clinics, Pharmacy Shops
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Roche Roche Diagnostics
- Lifescan
- Abbott Laboratories
- Terumo
- Ascensia (Bayer)
Highlights of The Self-monitoring Blood Glucose Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Strips
- Glucose Meter
- Lancet
- Other
- By Application:
- Public Hospital
- Private Hospital
- Clinics
- Pharmacy Shops
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Self-monitoring Blood Glucose Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Self-monitoring blood glucose devices (SMBGs) are a type of diabetes device that helps people with diabetes track their blood sugar levels. They work by measuring the amount of sugar in your blood and sending this information to a computer or other device. This allows you to see how your blood sugar is changing over time, and help you to keep track of your treatment goals.
Some of the key players operating in the self-monitoring blood glucose devices market are Roche Roche Diagnostics, Lifescan, Abbott Laboratories, Terumo, Ascensia (Bayer).
The self-monitoring blood glucose devices market is expected to grow at a compound annual growth rate of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Self-monitoring Blood Glucose Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Self-monitoring Blood Glucose Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Self-monitoring Blood Glucose Devices Market - Supply Chain
4.5. Global Self-monitoring Blood Glucose Devices Market Forecast
4.5.1. Self-monitoring Blood Glucose Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Self-monitoring Blood Glucose Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. Self-monitoring Blood Glucose Devices Market Absolute $ Opportunity
5. Global Self-monitoring Blood Glucose Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Type
5.3.1. Strips
5.3.2. Glucose Meter
5.3.3. Lancet
5.3.4. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Self-monitoring Blood Glucose Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Application
6.3.1. Public Hospital
6.3.2. Private Hospital
6.3.3. Clinics
6.3.4. Pharmacy Shops
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Self-monitoring Blood Glucose Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Self-monitoring Blood Glucose Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Self-monitoring Blood Glucose Devices Demand Share Forecast, 2019-2026
9. North America Self-monitoring Blood Glucose Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Application
9.4.1. Public Hospital
9.4.2. Private Hospital
9.4.3. Clinics
9.4.4. Pharmacy Shops
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Type
9.7.1. Strips
9.7.2. Glucose Meter
9.7.3. Lancet
9.7.4. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Self-monitoring Blood Glucose Devices Demand Share Forecast, 2019-2026
10. Latin America Self-monitoring Blood Glucose Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Application
10.4.1. Public Hospital
10.4.2. Private Hospital
10.4.3. Clinics
10.4.4. Pharmacy Shops
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Type
10.7.1. Strips
10.7.2. Glucose Meter
10.7.3. Lancet
10.7.4. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Self-monitoring Blood Glucose Devices Demand Share Forecast, 2019-2026
11. Europe Self-monitoring Blood Glucose Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Application
11.4.1. Public Hospital
11.4.2. Private Hospital
11.4.3. Clinics
11.4.4. Pharmacy Shops
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Type
11.7.1. Strips
11.7.2. Glucose Meter
11.7.3. Lancet
11.7.4. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Self-monitoring Blood Glucose Devices Demand Share, 2019-2026
12. Asia Pacific Self-monitoring Blood Glucose Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Application
12.4.1. Public Hospital
12.4.2. Private Hospital
12.4.3. Clinics
12.4.4. Pharmacy Shops
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Type
12.7.1. Strips
12.7.2. Glucose Meter
12.7.3. Lancet
12.7.4. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Self-monitoring Blood Glucose Devices Demand Share, 2019-2026
13. Middle East & Africa Self-monitoring Blood Glucose Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Application
13.4.1. Public Hospital
13.4.2. Private Hospital
13.4.3. Clinics
13.4.4. Pharmacy Shops
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Self-monitoring Blood Glucose Devices Market Size and Volume Forecast by Type
13.7.1. Strips
13.7.2. Glucose Meter
13.7.3. Lancet
13.7.4. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Self-monitoring Blood Glucose Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Self-monitoring Blood Glucose Devices Market: Market Share Analysis
14.2. Self-monitoring Blood Glucose Devices Distributors and Customers
14.3. Self-monitoring Blood Glucose Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Roche Roche Diagnostics
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Lifescan
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Abbott Laboratories
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Terumo
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Ascensia (Bayer)
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook